ACRV
Price
$1.41
Change
+$0.06 (+4.44%)
Updated
Jul 21, 03:42 PM (EDT)
Capitalization
42.33M
18 days until earnings call
AURA
Price
$6.85
Change
+$0.14 (+2.09%)
Updated
Jul 21, 03:47 PM (EDT)
Capitalization
416.05M
17 days until earnings call
Interact to see
Advertisement

ACRV vs AURA

Header iconACRV vs AURA Comparison
Open Charts ACRV vs AURABanner chart's image
Acrivon Therapeutics
Price$1.41
Change+$0.06 (+4.44%)
Volume$100
Capitalization42.33M
Aura Biosciences
Price$6.85
Change+$0.14 (+2.09%)
Volume$200
Capitalization416.05M
ACRV vs AURA Comparison Chart in %
Loading...
ACRV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
AURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACRV vs. AURA commentary
Jul 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACRV is a Hold and AURA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 21, 2025
Stock price -- (ACRV: $1.35 vs. AURA: $6.71)
Brand notoriety: ACRV and AURA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACRV: 56% vs. AURA: 97%
Market capitalization -- ACRV: $42.33M vs. AURA: $416.05M
ACRV [@Biotechnology] is valued at $42.33M. AURA’s [@Biotechnology] market capitalization is $416.05M. The market cap for tickers in the [@Biotechnology] industry ranges from $286.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.44B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACRV’s FA Score shows that 1 FA rating(s) are green whileAURA’s FA Score has 0 green FA rating(s).

  • ACRV’s FA Score: 1 green, 4 red.
  • AURA’s FA Score: 0 green, 5 red.
According to our system of comparison, both ACRV and AURA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACRV’s TA Score shows that 4 TA indicator(s) are bullish while AURA’s TA Score has 4 bullish TA indicator(s).

  • ACRV’s TA Score: 4 bullish, 3 bearish.
  • AURA’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, both ACRV and AURA are a good buy in the short-term.

Price Growth

ACRV (@Biotechnology) experienced а +2.27% price change this week, while AURA (@Biotechnology) price change was -0.89% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.79%. For the same industry, the average monthly price growth was +16.27%, and the average quarterly price growth was +35.62%.

Reported Earning Dates

ACRV is expected to report earnings on Aug 08, 2025.

AURA is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+2.79% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AURA($416M) has a higher market cap than ACRV($42.3M). AURA YTD gains are higher at: -18.370 vs. ACRV (-77.575). ACRV has higher annual earnings (EBITDA): -92.1M vs. AURA (-101.63M). ACRV has more cash in the bank: 150M vs. AURA (128M). ACRV has less debt than AURA: ACRV (3.51M) vs AURA (18.4M). ACRV (0) and AURA (0) have equivalent revenues.
ACRVAURAACRV / AURA
Capitalization42.3M416M10%
EBITDA-92.1M-101.63M91%
Gain YTD-77.575-18.370422%
P/E RatioN/AN/A-
Revenue00-
Total Cash150M128M117%
Total Debt3.51M18.4M19%
TECHNICAL ANALYSIS
Technical Analysis
ACRVAURA
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 4 days ago
82%
MACD
ODDS (%)
N/A
Bullish Trend 4 days ago
78%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
81%
Bearish Trend 4 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
86%
Bullish Trend 4 days ago
75%
Advances
ODDS (%)
Bullish Trend 4 days ago
87%
Bullish Trend 5 days ago
77%
Declines
ODDS (%)
Bearish Trend 22 days ago
89%
Bearish Trend 7 days ago
83%
BollingerBands
ODDS (%)
N/A
Bearish Trend 4 days ago
85%
Aroon
ODDS (%)
Bearish Trend 7 days ago
89%
Bullish Trend 4 days ago
75%
View a ticker or compare two or three
Interact to see
Advertisement
ACRV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
AURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LTBR15.070.18
+1.21%
Lightbridge Corp
BUSE24.370.21
+0.87%
First Busey Corp
GS708.262.42
+0.34%
Goldman Sachs Group
ORRF33.570.02
+0.06%
Orrstown Financial Services
FYBR36.88N/A
N/A
Frontier Communications Parent

ACRV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACRV has been loosely correlated with ALLR. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ACRV jumps, then ALLR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACRV
1D Price
Change %
ACRV100%
+2.27%
ALLR - ACRV
46%
Loosely correlated
-0.34%
AURA - ACRV
40%
Loosely correlated
-5.76%
HUMA - ACRV
39%
Loosely correlated
-3.72%
CCCC - ACRV
39%
Loosely correlated
+6.42%
MGNX - ACRV
39%
Loosely correlated
N/A
More

AURA and

Correlation & Price change

A.I.dvisor indicates that over the last year, AURA has been loosely correlated with IDYA. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if AURA jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AURA
1D Price
Change %
AURA100%
-5.76%
IDYA - AURA
53%
Loosely correlated
-2.26%
VRDN - AURA
52%
Loosely correlated
-3.11%
MGTX - AURA
52%
Loosely correlated
N/A
BEAM - AURA
50%
Loosely correlated
+1.47%
XNCR - AURA
49%
Loosely correlated
-1.10%
More